BCAP31 and gastric cancer: It is of note that BRCA, ESCA, HNSC and LGG patients with low BAP31 expression had longer overall survival (OS) than those with high expression (log-rank, p < 0.05), as determined in Kaplan–Meier analysis of the TCGA GC cohort (Supplementary Fig. S1B).